Coronary heart disease Acute coronary syndrome in human immunodeficiency virus-infected patients : characteristics and 1 year prognosis

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . CLINICAL RESEARCH Coronary heart disease

[1]  R. Napoli,et al.  Human immunodeficiency virus per se exerts atherogenic effects. , 2009, Atherosclerosis.

[2]  P. Morlat,et al.  Changes in Causes of Death Among Adults Infected by HIV Between 2000 and 2005: The “Mortalité 2000 and 2005” Surveys (ANRS EN19 and Mortavic) , 2008, Journal of acquired immune deficiency syndromes.

[3]  Hang Lee,et al.  Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  H. Sørensen,et al.  Ischemic heart disease in HIV-infected and HIV-uninfected individuals: a population-based cohort study. , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  O. Kirk,et al.  Class of antiretroviral drugs and the risk of myocardial infarction. , 2007, The New England journal of medicine.

[6]  B. Strauss,et al.  Outcome of percutaneous coronary intervention in HIV‐infected patients , 2006, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  J Darbyshire,et al.  CD4+ count-guided interruption of antiretroviral treatment. , 2006, The New England journal of medicine.

[8]  Jeffrey N. Martin,et al.  Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses , 2006, AIDS.

[9]  John T Brooks,et al.  Mortality in the Highly Active Antiretroviral Therapy Era: Changing Causes of Death and Disease in the HIV Outpatient Study , 2006, Journal of acquired immune deficiency syndromes.

[10]  J. Stein.  Cardiovascular risk in patients with human immunodeficiency virus infection: incomplete data. , 2006, Journal of the American College of Cardiology.

[11]  E. Di Angelantonio,et al.  Percutaneous coronary intervention in HIV infected patients: immediate results and long term prognosis , 2005, Heart.

[12]  Á. Avezum,et al.  A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. , 2004, Journal of the American Medical Association (JAMA).

[13]  D. Waters,et al.  Clinical Features of Acute Coronary Syndromes in Patients With Human Immunodeficiency Virus Infection , 2004, Circulation.

[14]  D. Costagliola,et al.  Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men , 2003, AIDS.

[15]  J. Ambrose,et al.  Frequency of and outcome of acute coronary syndromes in patients with human immunodeficiency virus infection. , 2003, The American journal of cardiology.

[16]  D. Arveiler,et al.  Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  A. Simon,et al.  Coronary artery disease in HIV infected patients , 2003, Intensive Care Medicine.

[18]  S. Kaul,et al.  Acute myocardial infarction in human immunodeficiency virus-infected patients. , 2003, Archives of internal medicine.

[19]  J. Herlitz,et al.  Ten year mortality in subsets of patients with an acute coronary syndrome , 2001, Heart.

[20]  Hugo A. Katus,et al.  Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. , 2000, European heart journal.

[21]  S M Marcovina,et al.  Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. , 1999, Circulation.

[22]  L. Fisher,et al.  Myocardial infarction in young adults: angiographic characterization, risk factors and prognosis (Coronary Artery Surgery Study Registry). , 1995, Journal of the American College of Cardiology.

[23]  E J Topol,et al.  Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group. , 1990, Circulation.

[24]  R. Hornung,et al.  Ischemic cardiovascular disease in persons with human immunodeficiency virus infection. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.